ICPE 2018 Prague Schedule

Go to Main RTI-HS ICPE Prague Webpage

Wednesday, 22 Aug | ICPE Pre-Conference Educational Session Contribution 

8:30 am –
12:30 pm 

Effective risk management: best practices for designing, implementing and evaluating risk minimization programs.  Auth D, Gilsenan A, Morrato E, Smith M, Wise L. 

Thursday, 23 Aug | ICPE Pre-Conference Educational Session Contributions 

8:30 am –
12:30 pm 

Modern pregnancy pharmacoepidemiology: minimizing biases in various study designs.  Bateman B, Hernandez-Diaz S, Huybrechts K, Margulis AV, Reefhuis J. 

8:30 am –
12:30 pm

Practical Skills in Protocol Writing and Statistical Analytic Programming Relevant to Pharmacoepidemiology. Hampp C, Jalbert J, Pratt CY, Pratt N, Ritchey ME

2:00 – 6:00 pm  

Medical device epidemiology. Anderson-Smits C, Asiimwe A, Jalbert J, Lystig T, Mack C, Prieto-Alhambra D, Ritchey ME.  

2:00 – 6:00 pm 

Weighing the benefits & risks: the science and methods of benefit-risk assessment in drug development. Hammad T, Hauber AB, Juhaeri J, Noel R.

Friday, 24 Aug | ICPE Scientific Session Contributions 

8:00 am – 6:00 pm posters 

Are you really dead? Validation of death and date of death in patients with COPD in CPRD [261]. Rivero-Ferrer ECastellsague JAguado JPlana ESaigi NGarcia-Gil E, Perez-Gutthann SRebordosa C.  [Methods - Validation Studies Poster]

To pile or not to pile: how to define episodes of use of COPD medications in the CPRD [263]. Plana ERebordosa CAguado JSaigi N, Garcia E, Castellsague JPerez-Gutthann S.  [Methods - Validation Studies Poster]

Validation of uterine perforation and intrauterine device expulsion in electronic health records [272]. Saltus CWAnthony MSArmstrong MA, Postlethwaite D, Getahun D, Xie F, Gatz J, Grafton J, Merchant M, Ichikawa L, Fassett M, Schulze-Rath R, Asiimwe A.  [Methods - Validation Studies Poster] 

Feasibility of assessing breastfeeding status in electronic health records [260]. Anthony MS, Getahun D, Alabaster AL, Cronkite D, Gatz J, Merchant M, Chiu VY, Armstrong MA, Ritchey ME, Fassett M, Schoendorf J, Asiimwe A.  [Methods - Validation Studies Poster]

A comparison of record linkage software and algorithms using real-world data [189]. West SKarr A, Taylor MT, Setoguchi S, Kou D, Gerhard T, Horton DB. [Data Linkage Poster]

Linking Electronic Health Data in Pharmacoepidemiology: Guidance for Assessing Appropriateness and Feasibility [185] Rivera DR, Gokhale MN, Reynolds MW, Andrews EB, Chun D, Haynes K, Jonsson-Funk ML, Lynch KE, Lund JL, Strongman H, Raman SR. [Data Linkage Poster]

12:15 – 1:15 pm SPOTLIGHT
poster session 

Characterization of patients with ulcerative colitis in a postauthorization safety study of golimumab based in the Spanish ENEIDA Registry [98]. Fortuny JRasouliyan L, Mines D, Tormos A, Earley E, Perez-Gutthann S, Domenech E, Gisbert JP.  [Biologistics and Biosimilars SPOTLIGHT Poster]

Patients' perceptions of unmet medical need in rheumatoid arthritis [116]. Curtis J, Genovese M, Radawski C, Hauber AB, Nowell WB, Hollis K, Gaich C.  [Digital Epidemiology SPOTLIGHT Poster]

Comparison of propensity score (PS) weighting and trimming strategies to reduce variance and bias of treatment effect estimates: a simulation study [110] Sturmer T, Rothman KJ, Ellis AR, Wyss R, Conover M, Lunt M, Glynn RJ. [CER SPOTLIGHT Poster]

1:30 – 1:45 pm

Agomelatine and other antidepressants and the risk of acute liver injury (ALI), a pass in four European countries [36]. Pladevall-Vila M, Hallas J, Schink T, Reutfors J, Morros R, Poblador-Plou B, Forns J, Hellfritzsch M, Reinders T, Hagg D, Giner-Soriano M, Prados-Torres A, Cainzos-Achirica M, Pottegard A, Kollhorst B, Brandt L, Cortes J, Aguado J, Perlemuter G, Castellsague J, Jacquot E, Deltour N, Perez-Gutthann S. [Psychotropics – The More It Changes, The More It's The Same – Podium Presentation]

5:00 – 5:15 pm

Propensity score matching versus propensity score fine stratification and coarsened exact matching in claims data [47] Ripollone JE, Huybrechts KF, Rothman KJ, Ferguson RE, Franklin JM. [PS I Still Love You Podium Presentation]

5:00 – 6:30 pm

Drugs in Pregnancy: Anti-infectives, Anti-asthmatics, MS drugs, & TNFs. Kawai AT. Co-moderator of a podium session.

Saturday, 25 Aug | ICPE Scientific Session Contributions 

8:00 am – 6:00 pm

Do ICPE pregnancy abstracts make it to term? [522]. Rivero-Ferrer E, Martinez D, Rasouliyan L, Anthony MS, Margulis AV, Perez-Gutthann S.  [Pregnancy and Lactation Poster]

Antiepileptic drugs in pregnancy and duration of pregnancy, birth weight, length and head circumference [505]. Margulis AV, D'Onofrio B, Almqvist C, McElrath T, Oberg AS, Plana ERothman KJ, Hernandez-Diaz S.  [Pregnancy and Lactation Poster]

A novel approach for active surveillance of pregnancy safety in multiple sclerosis [583]. Didden E-M, Andrews EB, Hellwig K, Hernandez-Diaz S, Magyari M, Margulis AVRivero-Ferrer E, Bader-Weder S, Klingelschmitt G, Wormser D.  [Pharmacovigilance - Nervous System Poster]

Estimating influenza vaccine effectiveness: using an active comparator reduces bias due to confounding by frailty [493]. Butler AM, Layton JB, Krueger WS, Kshirsagar AV, McGrath LJ.  [Study Design and Bias Poster]

Validity of hospital ICD-10-GM codes to identify acute liver injury [568] Timmer A, Kappen S, de Sordi D, Pladevall MPerez-Gutthann S, Jacquot E, Deltour N, Schink T. [Pharmacovigilance - Methods/Data Poster]

8:00 – 8:15 am

Effectiveness of prenatal Tdap immunization in the prevention of infant pertussis in the US. [368] Becker-Dreps S, Butler AM, McGrath LJ, Boggess KA, Weber DJ, Li D, Hudgens MG, Layton JB.  [Advances in Vaccine Safety Monitoring Podium Presentation]

8:00 – 9:30 am

Diabetes All Mixed Up. Margulis AV Co-moderator of a podium session.

11:45 am – 12:45 pm
poster session

The missing puff: results of multiple imputation of ppFEV1 in CPRD [455]. Aguado JPlana ESaigi N, Garcia E, Castellsague JPerez-Gutthann SRebordosa C. [Databases SPOTLIGHT Poster]

Evaluation of physician knowledge of safety and safe use information for aflibercept [446]. Zografos LAndrews EBCalingaert BDavenport EWolin D, Vassilev Z.  [BRACE SPOTLIGHT Poster]

Can electronic health records be used to identify medical procedure–related events indicative of difficult insertion of intrauterine devices? [471]. Ritchey ME, Postlethwaite D, Reed SD, Getahun DT, Gatz J, Lynen R, Saltus CW, Alabaster AL, Im TM, Takhar HS, Asiimwe A.  [Medical Devices SPOTLIGHT Poster]

1:00 – 2:00 pm

Pediatric potpourri. Margulis AV Co-moderator of a podium session.

4:00 – 5:30 pm

Ten years of ENCePP. Time to celebrate and move forward [437] Arana A, Kurz X, Perez-Gutthann S, Yates L, Trifiro G, Schneeweis S, Verpillat P, Vlcek J. [Concurrent Symposia/Workshops]

4:00 – 5:30 pm

Patient-focused benefit-risk assessment:  why, when and how should epidemiologists get involved [439] DiSantostefano R, Russo L, Marsh K, Cave A, Kurz X, Hauber ABAndrews EB [Concurrent Symposia/Workshops]

Sunday, 26 Aug | ICPE Scientific Session Contributions

8:00 am – 1:45 pm

Time between laboratory tests and acute liver and kidney injury diagnosis codes in CPRD: are we doing it right? [988]. Tormos ARebordosa CThomas SPlana E, Rasouliyan L, Pladevall-Vila M, Fazeli-Farsani S, Deruaz-Luyet A, Brodovicz KG, Perez-Gutthann S.  [Pharmacovigilance - Alimentary Tract and Metabolism Poster]

Short-term HDL cholesterol (HDL-C) decrease and incidence of cardiovascular (CV) events [1026]. Requena G, DiBello J, Ma L, Sturmer T, Layton JB. [Pharmacovigilance - Cardiovascular Poster]

Cardiovascular (CV) safety of phentermine and topiramate in a United States claims database [983]. Ritchey MEHunter S, Peterson C, Nguyen L, Thomas SHarding AAndrews EBRothman KJCainzos-Achirica MAnthony MS.  [Pharmacovigilance - Alimentary Tract and Metabolism Poster]

Real-world evidence for drugs and devices: 2017 literature reviewed [896]. Ritchey ME, Buck PM, Castro CFernandez MHollis KMordin M.  [Drug Effectiveness - Other Poster]

Limitations in reporting "benefit-risk" across therapeutic areas in medical device literature [1129]. Krueger WS, Young JC, Hollis KHauber ABGilsenan ARitchey ME.  [Benefit-Risk Assessment, Communication and Evaluation Poster]

Evaluation of patient knowledge of safety and safe use information for aflibercept [1141]. Zografos LAndrews ECalingaert BDavenport EWolin D, Vassilev Z.  [Benefit-Risk Assessment, Communication and Evaluation Poster]

8:45 – 9:00 am

A word of caution: all-cause mortality and residual confounding in Medicare claims data [751]. Garcia-Albeniz X, Hsu J, Hernan MA.  [A Methods Stew Podium Presentation]

9:00 – 9:15 am

Potential for using external control arms derived from electronic health records to replace control arms from randomized controlled trials [782] Carrigan G, Whipple S, Capra WB, Taylor MD, Lu M, Arnieri B, Brown JS, Abernethy AP, Copping R, Rothman KJ. [Cancer Treatment, Lessons from Three Continents Podium Presentation]

10:30 am – 12:00 pm

It takes a village part II: workshop to reconsider core competencies for new generations in the global and rapidly changing community of pharmacoepidemiology [788] Setoguchi S, Stang P, Perez-Gutthann S, May F, Klungel O, Strom B, Sahin L, Caduff P, Zhou W, Young JC, Chou Su C, Hester L, Zhu Y, Cesta C, Ahad MZ, Horton D, Hernandez-Diaz S. [Concurrent Symposia/Workshops]

12:15 – 1:15 pm

Developing the infrastructure to assess pregnancy outcomes following vaccination: influenza vaccines and spontaneous abortion as a use case [863]. Kawai AT, Reidy M, Zichittella L, Stockdale C, Longley E, Walraven C, Liu C, Shoaibi A, Feibelmann S, Lee GM. [Vaccines SPOTLIGHT Poster Winner]

1:30 – 3:00 pm

Safety in Numbers: Assessing Interventions and Outcomes Layton JB. Co-moderator of a podium session.

2:00 – 2:15 pm

How valid are the codes used to identify acute liver injury (ALI)? A study in 3 European data sources [811]. Forns JCainzos-Achirica M, Hellfritzsch M, Giner-Soriano M, Poblador-Plou B, Hallas J, Morros R, Prados-Torres A, Pottegard A, Cortes J, Aguado J, Castellsague J, Jacquot E, Deltour N, Perez-Gutthann SPladevall M. [Algorithms: Rarely Pure and Never Simple Podium Presentation]